- Case
Publication of misleading information and publication
I analysed the results of a randomised controlled trial that had just been completed by some of my colleagues. The trial compared an oxygen radical scavenger with a placebo in patients with acute myocardial infarction. One of the major outcome measures included infarct size,as measured by nuclear imaging. My analysis showed that there was no significant difference between groups for either of t… - Case
Overseas editor dismissed from university for fraud
An international specialist medical journal has editors in the UK and abroad who function independently. An issue of a scientific journal in 1998 reported that the overseas editor had been dismissed from a university professorship because of scientific fraud. This had been documented in three published research papers.The report highlighted a particular paper, in which 27 references cited indic… - Case
Surprising results and a new area of research
A paper described an unusual approach to disease modulation in an experimental animal model. The apparently clear cut findings were somewhat surprising. The authors also seem to have used high and low power photomicrographs of the same tissue sections to illustrate completely different experiments within the study. This occurred twice in the paper. Furthermore, this particular area of study was… - Case
Triplicate publication with possibly different data in each
A paper describing an outbreak of infectious disease was submitted to three journals. The submission to one journal described the index case; the submission to another included investigation and follow up of other cases and contacts in the country where the outbreak had occurred. The third paper looked at the spread of the disease into other countries. A considerable amount of the epidem… - Case
Grounds for retraction?
The co-author of a paper has contacted us about a paper he published 5 years ago together with a researcher who has now been convicted of serious professional misconduct by the GMC for research misconduct. The co-author is worried that the paper he co-authored may also be fraudulent. The research was in two parts. The first was analysed by a doctor not convicted of research miscon… - Case
Failing to get consent from an ethics committee
This case was described to me by an author who is about to submit a paper. He has discovered that a member of his team has produced a lot of fraudulent data for other studies, and has forged consent from ethics committees. This researcher has been reported to the GMC and his case is pending. The problem with the paper about to be submitted to us is that the fraudulent researcher falsely claime… - Case
The perfect study but no investigational drug
A paper was submitted that described the use of a non-licensed investigational drug. One of the paper’s reviewers drew attention to the fact that none of the investigators in the study had been supplied with the drug since 1992/3. The drug is produced exclusively by one manufacturer who has operated an extremely restrictive policy regarding availability of the compound. I contacted the clinical… - Case
Suspected fabrication of data
A reviewer expressed suspicion that data were manufactured. We wrote to the authors saying that our reviewer would like to see the original data. The author replied that this research was carried out in the USA. We then wrote back suggesting that his co-workers in the US would probably be delighted that this work was being submitted for publication and would happily send over the data but that…